Atlas Trials

Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC

Clinical trial NCT04153097 · UNKNOWN

Trial details

NCT number
NCT04153097
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2020-07-30
Primary completion
2023-12-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.